Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Smurfit Kappa GP M&A Activity 2018

May 21, 2018

1952_rns_2018-05-21_7d42d16c-b447-4fb3-bafb-e527db1d9ef2.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7630O

Northern Trust Corporation

21 May 2018

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1) Northern Trust Group
Company dealt in International Paper Company
Class of relevant security to which the dealings being disclosed relate (Note 2) USD1.00 common stock
Date of dealing 18th  May 2018

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long Short
Number (%) Number (%)
(1) Relevant securities 4,979,172     1.20%
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total 4,979,172     1.20%

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale Number of relevant securities Price per unit ($)
SELL 979 54.96
SELL 134 55.0102
SELL 2065 54.96
BUY 5 55.11
BUY 4 55.11
BUY 7 55.14
BUY 8 55.11
BUY 10 55.11
BUY 3 55.14
BUY 14 55.14
BUY 13 55.11
BUY 3 55.14
BUY 13 54.96
BUY 11 55.11
BUY 8 55.14
BUY 42 55.11
BUY 5 55.11
BUY 41 55.11
BUY 15 55.11
BUY 12 55.11
BUY 17 55.14
BUY 6 55.11
BUY 48 55.11
BUY 7 55.11
BUY 100 55.08
BUY 6 55.11
BUY 60 55.11
BUY 42 55.11
BUY 7 55.11
BUY 6 55.14
BUY 10 55.11
BUY 42 55.11
BUY 29 55.11
BUY 13 55.14
BUY 188 54.96
BUY 206 54.96
BUY 11 54.96
BUY 12 55.14
BUY 9 55.11
SELL 600 55.06

(b)      Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing

and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant 

securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            NO

Date of disclosure 21st  May 2018
Contact name Alexandra Marshall-Grant
Telephone number 020 7982 1844
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ISEPGUWCAUPRGWG